Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that the Shareholder Class Action Against Myriad Genetics, Inc. (NASDAQ: MYGN) has survived the
motions to dismiss in the pending securities class action and may face damages. Long-term investors are encouraged to contact the firm.

According to the securities class action complaint, throughout the Class